Literature DB >> 25032907

Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses.

Catherine E M Hogwood1, Daniel G Bracewell2, C Mark Smales3.   

Abstract

Chinese hamster ovary (CHO) cells are widely used for the production of biotherapeutic recombinant proteins for a range of molecules including monoclonal antibodies and Fc-fusion proteins. Regulatory requirements for the final product include the removal of host cell proteins (HCPs) to acceptable amounts (<100ppm). Recent research has begun to unravel the extent to which upstream process conditions and subsequent product recovery and purification processes impact upon the HCP profile. A number of upstream parameters, including the selection of the cell line, the culturing process (e.g. feeding regime, culture temperature), cell viability at time of harvest/culture duration and cell shear sensitivity can all influence the resulting HCP profile. Further, the molecule itself plays an important role in determining those HCPs that are retained throughout a bioprocess and HCPs can co-elute with the target product during purification. Measurement and monitoring of HCPs is usually undertaken using ELISA technology, however alternative approaches are also now emerging that complement ELISA and allow the detection, identification and monitoring of specific HCPs. Here we discuss our understanding of how the process itself influences those HCPs present throughout the production process and the challenges in their monitoring, measurement and removal.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25032907     DOI: 10.1016/j.copbio.2014.06.017

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  11 in total

1.  Proteogenomic Annotation of Chinese Hamsters Reveals Extensive Novel Translation Events and Endogenous Retroviral Elements.

Authors:  Shangzhong Li; Seong Won Cha; Kelly Heffner; Deniz Baycin Hizal; Michael A Bowen; Raghothama Chaerkady; Robert N Cole; Vijay Tejwani; Prashant Kaushik; Michael Henry; Paula Meleady; Susan T Sharfstein; Michael J Betenbaugh; Vineet Bafna; Nathan E Lewis
Journal:  J Proteome Res       Date:  2019-05-08       Impact factor: 4.466

2.  Characterization and Value Assignment of a Monoclonal Antibody Reference Material, NMIJ RM 6208a, AIST-MAB.

Authors:  Tomoya Kinumi; Kazumi Saikusa; Megumi Kato; Reiko Kojima; Chieko Igarashi; Naohiro Noda; Shinya Honda
Journal:  Front Mol Biosci       Date:  2022-06-06

Review 3.  The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.

Authors:  Daniel G Bracewell; Richard Francis; C Mark Smales
Journal:  Biotechnol Bioeng       Date:  2015-07-14       Impact factor: 4.530

4.  Ribosome profiling-guided depletion of an mRNA increases cell growth rate and protein secretion.

Authors:  Thomas Beuchert Kallehauge; Shangzhong Li; Lasse Ebdrup Pedersen; Tae Kwang Ha; Daniel Ley; Mikael Rørdam Andersen; Helene Faustrup Kildegaard; Gyun Min Lee; Nathan E Lewis
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

5.  Influence of Escherichia coli chaperone DnaK on protein immunogenicity.

Authors:  Kirsty D Ratanji; Jeremy P Derrick; Ian Kimber; Robin Thorpe; Meenu Wadhwa; Rebecca J Dearman
Journal:  Immunology       Date:  2016-12-07       Impact factor: 7.397

6.  Cathepsin L Causes Proteolytic Cleavage of Chinese-Hamster-Ovary Cell Expressed Proteins During Processing and Storage: Identification, Characterization, and Mitigation.

Authors:  Haibin Luo; Liu Tie; Mingyan Cao; Alan K Hunter; Timothy M Pabst; Jiali Du; Raymond Field; Yuling Li; William K Wang
Journal:  Biotechnol Prog       Date:  2018-11-04

Review 7.  Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals.

Authors:  Joannes A A Reijers; Karen E Malone; Jeffrey J Bajramovic; Richard Verbeek; Jacobus Burggraaf; Matthijs Moerland
Journal:  Br J Clin Pharmacol       Date:  2019-05-29       Impact factor: 4.335

Review 8.  Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays.

Authors:  Axel Ducret; Chloé Ackaert; Juliana Bessa; Campbell Bunce; Timothy Hickling; Vibha Jawa; Mark A Kroenke; Kasper Lamberth; Anaïs Manin; Hweixian L Penny; Noel Smith; Grzegorz Terszowski; Sophie Tourdot; Sebastian Spindeldreher
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

9.  Antibody mix-and-read assays based on fluorescence intensity probes.

Authors:  Ujwal Patil; Atul Goyal; Binh Vu; Yanyun Liu; Vijay Maranholkar; Katerina Kourentzi; James M Briggs; Richard C Willson
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

10.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ - a study of an industrial mAb producing CHO-S cell line.

Authors:  Lesley M Chiverton; Caroline Evans; Jagroop Pandhal; Andrew R Landels; Byron J Rees; Peter R Levison; Phillip C Wright; C Mark Smales
Journal:  Biotechnol J       Date:  2016-06-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.